AP Biosciences Inc (6945)

Currency in TWD
117.50
+2.50(+2.17%)
Closed·
6945 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
112.00118.50
52 wk Range
104.50134.50
Key Statistics
Prev. Close
-
Open
115
Day's Range
112-118.5
52 wk Range
104.5-134.5
Volume
157.95K
Average Volume (3m)
297.09K
1-Year Change
-
Book Value / Share
27.18
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
6945 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Earnings

Latest Release
13/08/2026
EPS / Forecast
-1.43 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

6945 Income Statement

Compare 6945 to Peers and Sector

Metrics to compare
6945
Peers
Sector
Relationship
P/E Ratio
−24.2x34.6x−0.2x
PEG Ratio
1.501.740.00
Price/Book
4.8x3.6x2.6x
Price / LTM Sales
-7.3x2.8x
Upside (Analyst Target)
-23.3%62.3%
Fair Value Upside
Unlock17.4%8.2%Unlock

AP Biosciences, Inc. researches and develops protein and antibody drugs for unmet medical needs. It develops IBI302 that is in phase III clinical trials for the treatment of neovascular age-related macular degeneration; AP505 that is in phase I clinical trials for treating solid tumors; AP203 that is in phase I clinical trial for non-small cell lung cancer, head and neck squamous cell carcinoma, and esophageal squamous-cell carcinomas; AP402, which is in the pre-clinical research phase for breast cancer patients; and AP601 that is in pre-clinical research phase for treating lung cancer, pancreatic cancer, bladder cancer, ovarian cancer, and other solid tumors. It caters to healthcare and biotechnology industries. AP Biosciences, Inc. has strategic collaboration with Delos Capital to discover and develop novel immune-related drug candidates through early clinical proof of concept. The company was founded in 2013 and is based in Taipei, Taiwan.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
48.00K0.05%5.38M
Other Institutional Investors
42.62M43.94%4.77B
Public Companies & Retail Investors
54.33M56.01%6.08B
Total
96.99M100.00%10.86B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
OBI Pharma, Inc.23.94%23,223,0002,600,976
Huei Hong Investment Co., Ltd.4.99%4,837,546541,805

FAQ

What Is the AP Biosciences (6945) Stock Price Today?

The AP Biosciences stock price today is 117.50 TWD.

What Stock Exchange Does AP Biosciences Trade On?

AP Biosciences is listed and trades on the Taipei Exchange.

What Is the Stock Symbol for AP Biosciences?

The stock symbol for AP Biosciences is "6945."

What Is the AP Biosciences Market Cap?

As of today, AP Biosciences market cap is 11.46B TWD.

What Is AP Biosciences's Earnings Per Share (TTM)?

The AP Biosciences EPS (TTM) is -5.38.

From a Technical Analysis Perspective, Is 6945 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has AP Biosciences Stock Split?

AP Biosciences has split 0 times.

What is the current trading status of AP Biosciences (6945)?

As of 11/11/2026, AP Biosciences (6945) is trading at a price of 117.50 TWD, with a previous close of 0.00 TWD. The stock has fluctuated within a day range of 112.00 TWD to 118.50 TWD, while its 52-week range spans from 104.50 TWD to 134.50 TWD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.